Severe eosinophilic asthma: a roadmap to consensus

Roland Buhl(Johannes Gutenberg University Mainz), Stephen T. Holgate(Southampton General Hospital), Santiago Quirce(Hospital Universitario La Paz), Liam G. Heaney(Queen's University Belfast), Pascal Chanez(Centre National de la Recherche Scientifique), Ian Pavord(University of Oxford), Marc Humbert(Inserm), Leif Bjermer(Lund University), J. Christian Virchow(University of Rostock)
European Respiratory Journal
May 1, 2017
10.1183/13993003.00634-2017
Cited by 187

Related Papers

2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
|European Heart Journal|2022|3.6k
Benefits of omalizumab as add‐on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE
|Allergy|2004|1.1k
Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness
|Nature|2002|1.1k
Pathologic assessment of vasculopathies in pulmonary hypertension
|Journal of the American College of Cardiology|2004|713
Treatment strategies for allergy and asthma
|Nature reviews. Immunology|2008|687